welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 122 blog entries.

SSP issued for Paracetamol 240mg suppositories

In response to a significant ongoing disruption to the supply of Paracetamol 240mg suppositories , a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 17 March 2023, SSP051 provides that for every Paracetamol 240mg suppository originally prescribed, one Paracetamol 250mg suppository must be supplied. SSP051, authorised by the [...]

The post SSP issued for Paracetamol 240mg suppositories appeared first on PSNC Website.

By |March 17th, 2023|Lexpos News|Comments Off on SSP issued for Paracetamol 240mg suppositories

Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 100mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP049 Estradot® 100mcg patches expires at 23.59pm on Friday 17 March 2023. After this date, any prescriptions for Estradot® 100mcg patches must be [...]

The post Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches appeared first on PSNC Website.

By |March 17th, 2023|Lexpos News|Comments Off on Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches

MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (23)A/10 Date issued: 16 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 150mg prolonged-release tablets, PL01883/0340 SNOMED Code: 41468211000001100 Batch [...]

The post MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) appeared first on PSNC Website.

By |March 17th, 2023|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream. MSN/2023/028 Tier 2 – medium impact Date of issue 16th March 2023 Following intermittent supplies of capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream, these are now out of stock until end of June 2023. [...]

The post Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream appeared first on PSNC Website.

By |March 16th, 2023|Lexpos News|Comments Off on Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream

March 2023 Price Concessions 1st Update

The Department of Health and Social Care (DHSC) has today (15/03/2023) granted the following initial list of price concessions for March 2023. Drug Pack size Price concession Amisulpride 100mg tablets 60 £20.29 Amisulpride 200mg tablets 60 £33.92 Amisulpride 50mg tablets 60 £13.09 Amoxicillin 125mg/5ml oral suspension 100 £4.32 Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.80 [...]

The post March 2023 Price Concessions 1st Update appeared first on PSNC Website.

By |March 15th, 2023|Lexpos News|Comments Off on March 2023 Price Concessions 1st Update